iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-03-22
DOI
10.1038/s41467-019-09296-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer
- (2017) Xiangsheng Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
- (2017) Anshuman Panda et al. JNCI-Journal of the National Cancer Institute
- T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy
- (2017) Robert Sackstein et al. LABORATORY INVESTIGATION
- Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
- (2017) Anshuman Panda et al. JNCI-Journal of the National Cancer Institute
- iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes
- (2016) Lorena Simón-Gracia et al. BIOMATERIALS
- Gastric cancer
- (2016) Eric Van Cutsem et al. LANCET
- Regional but fatal: Intraperitoneal metastasis in gastric cancer
- (2016) Jia Wei et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
- (2016) Sarah Derks et al. Oncotarget
- CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer
- (2016) Shu Su et al. OncoImmunology
- A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis
- (2015) Kazuki N. Sugahara et al. JOURNAL OF CONTROLLED RELEASE
- IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumorsin vivo
- (2015) Mythili Koneru et al. OncoImmunology
- Trafficking of T Cells into Tumors
- (2014) C. Y. Slaney et al. CANCER RESEARCH
- Leukocyte Migration into Inflamed Tissues
- (2014) Sussan Nourshargh et al. IMMUNITY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
- (2014) I. Melero et al. Cancer Discovery
- Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors
- (2013) Irene Thomassen et al. INTERNATIONAL JOURNAL OF CANCER
- Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
- (2013) Matteo Bellone et al. Frontiers in Oncology
- Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
- (2011) E. K. Moon et al. CLINICAL CANCER RESEARCH
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
- (2010) K. N. Sugahara et al. SCIENCE
- Immune infiltration in human tumors: a prognostic factor that should not be ignored
- (2009) F Pagès et al. ONCOGENE
- C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
- (2009) T. Teesalu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor
- (2008) L. M. Acevedo et al. BLOOD
- Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration
- (2007) P. Turowski et al. JOURNAL OF CELL SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now